1 / 13

- Strategic information used for preparation - Monitoring & Evaluation - Challenges to overcome

Antiretroviral treatment programme in Thyolo district, Malawi Southern Region . MSF Luxembourg & Thyolo District Health Services. - Strategic information used for preparation - Monitoring & Evaluation - Challenges to overcome Dr. Roger Teck – July 1st, 2003. HIV/AIDS in Thyolo District.

Download Presentation

- Strategic information used for preparation - Monitoring & Evaluation - Challenges to overcome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antiretroviral treatment programme in Thyolo district, Malawi Southern Region.MSF Luxembourg & Thyolo District Health Services - Strategic information used for preparation - Monitoring & Evaluation - Challenges to overcome Dr. Roger Teck – July 1st, 2003

  2. HIV/AIDS in Thyolo District • Mainly rural population: 475,000 people • Prevalence level of HIV infection among pregnant mothers: around 21% • People living wih HIV/AIDS: about 50,000 • People with AIDS: 5,000 – 10,000?

  3. HIV Continuum of Care in Thyolo district (June, 2003) • 7 VCT sites and one PMTCT site: - 1,300 – 1,500 tested monthly - 35 – 40 % test HIV + • Close to 2,300 a-symptomatic and symptomatic HIV+ patients supported through HBC and health centres. • Access for TB patients (1,200 per year) to VCT (> 90 % uptake, > 70 % HIV+) and CTX prophylaxis. • 1,700 symptomatic HIV + patients registered at district hospital based HIV/AIDS clinic

  4. Strategic information (1) • Institutional back-up • Perspectives for sustainable financing • Through MSF • Global Fund • Other mechanisms

  5. Strategic information (2) • Policy environment allowing importation of generic ARV medicines • Elaboration of draft Malawi ART guidelines - Organisational framework - Objectives & targets (Global Fund proposal) - Input and output indicators - Eligibility criteria. - First line treatment regimens - Clinical guidance for drug toxicity & treatment failure - Monitoring & evaluation framework

  6. Strategic information (3) • Estimates on the burden of HIV infection and AIDS • Assessment of health facilities - District hospital and 9 health centres - Missionary hospital and 8 health centres • Community - Perception of HIV/AIDS and HIV/AIDS/TB services - Expectations on ART treatment.

  7. Over five years period: access to HAART for at least 50 % of people with AIDS Simplified clinical protocol Fixed drug combination With national staff Screening & preparation in HBC and PMTCT population Two HIV/ART clinics (two hospitals) Decentralisation through health centres Adherence follow-up through guardians and HBC Main target and strategies for “scaling up” of the ART programme

  8. Organisational plan for HIV/ART clinic • Infrastructure and staffing for the HIV/AIDS clinic to manage “in addition” a maximum of 700 patients during first 6 months of treatment: - One receptionist - Two “consultation units” (one clinical officer + nurse) - Two “ART units” with each one nurse counsellor - Patient archive and data base: data entry technician (supported by one expatriate medical doctor) • Patient flow: quick and slow circuit • Week programme

  9. Patient follow-up

  10. Programme Monitoring & Evaluation (1)according to Malawi treatment guidelines • Outcome Indicators of Global Fund targets • Similar to NTP M&E system • Paper- based - patient identity card/stamp (“health passport”) - patient master card (file) for registration of monthly treatment outcome, “functional” status, side effects and adherence - quarterly cohort analysis forms - drug security form

  11. Programme Monitoring & Evaluation (2)“Fuchsia” Software Electronic Data base • Epicentre and Mèdecins sans Fontieres • Monthly & cumulative reporting on: - HIV clinic - ART programme • Patient summaries

  12. Antiretroviral treatment programme update April 22nd - June 27th.

  13. Strategic information and monitoring & evaluation: challenges • WHO staging • Decentralisation to health centres: - Continuation of follow-up of ART for children - Drug security - Staff capacity - Monitoring & evaluation • Linking to other treatment centres - Transfers - ART “shopping”

More Related